Abstract The coronavirus disease 2019 (COVID‐19) pandemic is ongoing and many drugs
have been studied in clinical trials. From a pathophysiological perspective, anti‐viral drugs …

At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …

The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

COVID-19 has grown into a global pandemic that has strained healthcare throughout the
world. There is a sense of urgency in finding a cure for this deadly virus. In this study, we …

Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …

Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …

The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
has garnered the attention of scientists worldwide in the search for an effective treatment …

Introduction: Currently, there is no approved therapeutic entity for coronavirus disease 2019
(COVID-19) and clinicians are primarily relying on drug repurposing. However, findings …